openPR Logo
Press release

Hepatitis B Treatment Market Trends, Growth & Key Players 2024-2031 | Apotex Corp., Arbutus Biopharma, Arrowhead Pharma.

02-25-2025 07:52 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Hepatitis B Treatment Market

Hepatitis B Treatment Market

The Hepatitis B Treatment Market study by DataM Intelligence provides a comprehensive analysis of the market, delivering valuable insights, detailed statistics, historical trends, and industry-backed market data. The report explores the competitive landscape, focusing on key players in the industry. It evaluates aspects such as product offerings, pricing models, financial performance, product portfolios, growth strategies, and regional expansion to offer a thorough understanding of market dynamics and future trends.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/hepatitis-b-treatment-market?sz

What is the projected growth of the Global Hepatitis B Treatment market?

Global Hepatitis B Treatment Market reached USD 4.4 billion in 2022 and is expected to reach USD 5.9 billion by 2030 growing with a CAGR of 3.8% during the forecast period 2024-2031.

What is Hepatitis B Treatment Market?

The Hepatitis B Treatment Market focuses on antiviral drugs, immune modulators, and therapeutic vaccines aimed at managing chronic and acute hepatitis B infections. Driven by rising prevalence, increasing awareness, and advancements in biotechnology, the market is expanding. Innovations in combination therapies, long-acting treatments, and research on a functional cure further shape the evolving treatment landscape.

Transform your pharma strategy with expert insights and competitive analysis: https://www.datamintelligence.com/competitive-intelligence/contact

Who are the major players in the Hepatitis B Treatment market?

The prominent players in Hepatitis B Treatment market research report are:

Bristol-Myers Squibb, Gilead Sciences, Inc., GlaxoSmithKline, Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Arrowhead Pharma, Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., and Merck & Co. Inc., among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Key Development

On November 2, 2022, Gilead Sciences, Inc. announced that the U.S. FDA approved a supplemental new drug application (sNDA) for Vemlidy (tenofovir alafenamide) 25 mg tablets. This approval expands its use as a once-daily treatment for chronic hepatitis B virus (HBV) infection in pediatric patients aged 12 and older with compensated liver disease, offering a new treatment option for younger patients.

On November 1, 2022, Arcturus Therapeutics Holdings Inc., a leader in messenger RNA medicine development, announced a strategic partnership with CSL Seqirus, a global vaccine leader. This collaboration focuses on the research, development, manufacturing, and worldwide distribution of vaccines. CSL Seqirus, a division of CSL Limited, operates one of the largest influenza vaccine franchises globally, strengthening its position in vaccine innovation.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/hepatitis-b-treatment-market

Market Segments

By Type: Acute, Chronic.

By Treatment: Immune modulator Drugs, Antiviral Drugs, Vaccines, Surgery.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

The Hepatitis B Treatment industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Hepatitis B Treatment Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/hepatitis-b-treatment-market

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis B Treatment Market Trends, Growth & Key Players 2024-2031 | Apotex Corp., Arbutus Biopharma, Arrowhead Pharma. here

News-ID: 3884781 • Views:

More Releases from DataM Intelligence 4Market Research

United States Tobacco Testing Market Set for Strong Growth Amid Rising Health Regulations and Safety Standards 2025 | Top key players - Labstat International Inc., Essentra Scientific Services, Cerulean
United States Tobacco Testing Market Set for Strong Growth Amid Rising Health Re …
Market Overview: The Tobacco Testing Market is estimated to reach at a CAGR of 4% during the forecast period 2024-2031. The Tobacco Testing Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Tobacco Testing market report is an essential resource for market
United States Refractory Metals Market Set for Strong Growth Driven by High-Temperature Applications & Industrial Demand 2025 | Top key players - Terubacher Industrie AG, Rember Corporation, Codelco.
United States Refractory Metals Market Set for Strong Growth Driven by High-Temp …
Market Overview: The Refractory Metals Market is growing at a CAGR of 1.8% during the forecast period 2024-2031. The Refractory Metals Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Refractory Metals market report is an essential resource for market participants who
United States Alternative Proteins Market Set for Explosive Growth: Driving Sustainable Food Innovation 2025 | Major key players - Koninklijke DSM N.V, Kerry Group, DuPont.
United States Alternative Proteins Market Set for Explosive Growth: Driving Sust …
Market Size and Growth: The Global Alternative Proteins Market Size was valued at US$ 25.7 Billion in 2022 and is expected to reach USD 81.9 Billion by 2031, exhibiting a CAGR of 15.6% during the forecast period (2025-2032) The Alternative Proteins Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Meat Alternatives Market Surges as Consumers Embrace Plant-Based & Sustainable Protein Choices 2025 | Top key players - Vbites, MGP Ingredients, Monde Nissin Corporation.
United States Meat Alternatives Market Surges as Consumers Embrace Plant-Based & …
Market Size and Growth: The Global Meat Alternatives Market size value was USD 9.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 20.8 billion by 2031. The market is growing at a CAGR of 10.2% during the forecast period 2024-2031. The Meat Alternatives Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any